文献速递真菌感染

基因型对光滑念珠菌血流感染预后的意义

Implication of genotypes for prognosis of Candida glabrata bloodstream infections.
PubMed 文献 · J Antimicrob Chemother · 2024-01-01

对48株成人住院患者光滑念珠菌血流分离株进行MLST分型和UPGMA聚类,CC7为主要克隆群(29.2%),未发现CC7与特定耐药模式相关;多变量Cox回归显示CC7与28天死亡率独立相关(aHR 3.28,95%CI 1.31-8.23)。

要点

  • CC7占光滑念珠菌血流分离株29.2%,包含13株ST7。
  • CC7与28天死亡率独立相关,aHR 3.28(95%CI 1.31-8.23)。
  • 氟康唑耐药或棘白菌素治疗对死亡率无显著影响。

核心结论

  • 数据提示合并症患者有发生CC7血流感染的风险,且CC7与更差预后独立相关。

研究设计与样本

  • 对成人住院患者非重复光滑念珠菌血液分离株进行MLST分型,并以UPGMA聚类,克隆群定义为UPGMA相似性>90%;共评估48株血液分离株。

主要发现

  • 48株分离株共鉴定出13个ST型,CC7为最主要克隆群(n=14;29.2%),包含13株ST7。
  • 总体氟康唑耐药率为6.6%,棘白菌素耐药率为0%,未发现CC7或其他CC与特定耐药模式相关。
  • Charlson合并症指数是CC7的唯一预测因素(调整OR 1.49;95%CI 1.05-3.11)。
  • 多变量Cox回归显示CC7与28天死亡率独立相关(aHR 3.28;95%CI 1.31-8.23),考虑中性粒细胞减少交互作用后aHR 3.41(95%CI 1.23-9.42;交互作用P=0.24),仅限34例单一微生物血流感染患者时aHR 2.85(95%CI 1.15-7.08)。
  • Kaplan-Meier估计显示CC7组死亡率更高(P=0.003);氟康唑耐药或棘白菌素治疗对死亡率无显著影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genotyping isolates of a specific pathogen may demonstrate unique patterns of antimicrobial resistance, virulence or outcomes. However, evidence for genotype-outcome association in Candida glabrata is scarce. We aimed to characterize the mycological and clinical relevance of genotypes on C. glabrata bloodstream infections (BSIs). METHODS: Non-duplicated C. glabrata blood isolates from hospitalized adults were genotyped by MLST, and further clustered by the unweighted pair group method with arithmetic averages (UPGMA). A clonal complex (CC) was defined by UPGMA similarities of >90%. Antifungal susceptibility testing was performed by a colorimetric microdilution method and interpreted following CLSI criteria. RESULTS: Of 48 blood isolates evaluated, 13 STs were identified. CC7 was the leading CC (n = 14; 29.2%), including 13 ST7. The overall fluconazole and echinocandin resistance rates were 6.6% and 0%, respectively. No specific resistance patterns were associated with CC7 or other CCs. Charlson comorbidity index (adjusted OR, 1.49; 95% CI, 1.05-3.11) was the only predictor for CC7. By multivariable Cox regression analyses, CC7 was independently associated with 28 day mortality [adjusted HR (aHR), 3.28; 95% CI, 1.31-8.23], even after considering potential interaction with neutropenia (aHR, 3.41; 95% CI, 1.23-9.42; P for interaction, 0.24) or limited to 34 patients with monomicrobial BSIs (aHR, 2.85; 95% CI, 1.15-7.08). Also, the Kaplan-Meier estimate showed greater mortality with CC7 (P = 0.003). Fluconazole resistance or echinocandin therapy had no significant impact on mortality. CONCLUSIONS: Our data suggested comorbid patients were at risk of developing CC7 BSIs. Further, CC7 was independently associated with worse outcomes.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Chen PY, Huang YS, Chuang YC, et al. Implication of genotypes for prognosis of Candida glabrata bloodstream infections. J Antimicrob Chemother. 2024. PMID: 38906829. doi:10.1093/jac/dkae200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。